Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Feb 11:3:e02189.
doi: 10.7554/eLife.02189.

Bringing dead proteins back to life

Affiliations
Comment

Bringing dead proteins back to life

Brandon A Wustman et al. Elife. .

Abstract

A small molecule called EMD 57033 can repair motor proteins that have stopped working as a result of stress.

Keywords: allostery; myosin; pharmacological chaperone; protein folding.

PubMed Disclaimer

Conflict of interest statement

Competing interests:The authors declare that no competing interests exist.

Figures

Figure 1.
Figure 1.. The small molecule EMD 57033 mediates both activation and refolding of the myosin motor protein.
A myosin motor protein binds to a molecule of ATP, and releases the energy it contains by splitting it into an ADP molecule and a phosphate ion (Pi). After binding to a filament of actin (shown in green), the motor protein then uses this energy to ‘walk’ along the filament. Repeating this cycle generates a pulling force that can cause a muscle cell to contract—however, this effort, as well as other stresses within the muscle cell, can promote misfolding and a loss of motor function. The accumulation of misfolded ‘dead’ myosin can lead to the formation of protein aggregates, which can have potentially toxic effects. Radke, Taft et al. show that when EMD 57033 (not shown) binds to cardiac β-myosin it increases the rate of ATP binding and energy release (blue circular arrow), which accelerates the motor proteins progression along the actin filament. Remarkably, EMD 57033 can also refold some forms of misfolded myosin back to a properly folded and functional state (purple arrow)—an activity that has not been observed before for similar small molecules.

Comment on

References

    1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. 1995. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation 92:785–789. 10.1161/01.CIR.92.4.785 - DOI - PubMed
    1. Maron BJ. 2002. Hypertrophic cardiomyopathy: a systematic review. Journal of the American Medical Association 287:1308–1320. 10.1001/jama.287.10.1308 - DOI - PubMed
    1. Radke MB, Taft MH, Stapel B, Hilfiker-Kleiner D, Preller M, Manstein DJ. 2014. Small molecule-mediated refolding and activation of myosin motor function. eLife 3:e01603. 10.7554/eLife.01603 - DOI - PMC - PubMed
    1. Solaro RJ, Gambassi G, Warshaw DM, Keller MR, Spurgeon HA, Beier N, Lakatta EG. 1993. Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circulation Research 73:981–990. 10.1161/01.RES.73.6.981 - DOI - PubMed

MeSH terms

LinkOut - more resources